Markku Jalkanen

8.9k total citations
119 papers, 7.4k citations indexed

About

Markku Jalkanen is a scholar working on Cell Biology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Markku Jalkanen has authored 119 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Cell Biology, 76 papers in Molecular Biology and 33 papers in Immunology and Allergy. Recurrent topics in Markku Jalkanen's work include Proteoglycans and glycosaminoglycans research (74 papers), Glycosylation and Glycoproteins Research (37 papers) and Cell Adhesion Molecules Research (33 papers). Markku Jalkanen is often cited by papers focused on Proteoglycans and glycosaminoglycans research (74 papers), Glycosylation and Glycoproteins Research (37 papers) and Cell Adhesion Molecules Research (33 papers). Markku Jalkanen collaborates with scholars based in Finland, United States and Sweden. Markku Jalkanen's co-authors include Merton Bernfield, Markku Salmivirta, Klaus Elenius, Alan C. Rapraeger, Irma Thesleff, Seppo Vainio, S Jalkanen, Pirjo Inki, Markku Mali and Scott Saunders and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Markku Jalkanen

119 papers receiving 7.2k citations

Peers

Markku Jalkanen

GENET

Alan C. Rapraeger United States

Hans Kresse Germany

Charles B. Underhill United States

David T. Woodley United States

Caroline H. Damsky United States

Anne Woods United States

Giovanna Zambruno Italy

Beate Eckes Germany

Raija Tammi Finland

Randall H. Kramer United States

Alan C. Rapraeger United States

Markku Jalkanen

6.2k ×1.2

6.2k ×1.4

2.0k ×1.0

1.3k ×1.4

1.3k ×1.5

GENET

Citations per year, relative to Markku Jalkanen Markku Jalkanen (= 1×) peers Alan C. Rapraeger

Countries citing papers authored by Markku Jalkanen

Since Specialization

Citations

This map shows the geographic impact of Markku Jalkanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markku Jalkanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markku Jalkanen more than expected).

Fields of papers citing papers by Markku Jalkanen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markku Jalkanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markku Jalkanen. The network helps show where Markku Jalkanen may publish in the future.

Co-authorship network of co-authors of Markku Jalkanen

This figure shows the co-authorship network connecting the top 25 collaborators of Markku Jalkanen. A scholar is included among the top collaborators of Markku Jalkanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markku Jalkanen. Markku Jalkanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hollmén, Maija, Mikael Maksimow, Jenna H. Rannikko, et al.. (2022). Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers. Molecular Cancer Therapeutics. 21(7). 1207–1218. 9 indexed citations

Bono, Petri, Panu Jaakkola, Shishir Shetty, et al.. (2020). 1024MO A phase I/II MATINS trial: Part 1 pharmacokinetic, safety and efficacy results of Clever-1 blockade in advanced cancer. Annals of Oncology. 31. S706–S707. 1 indexed citations

Loo, Britt-Marie, et al.. (2002). Expression and Characterization of Minican, a Recombinant Syndecan-1 with Extensively Truncated Core Protein. Biochemical and Biophysical Research Communications. 290(1). 146–152. 10 indexed citations

Pursiheimo, Juha‐Pekka, et al.. (2002). Cooperation of Protein Kinase A and Ras/ERK Signaling Pathways Is Required for AP-1-mediated Activation of Fibroblast Growth Factor-inducible Response Element (FiRE). Journal of Biological Chemistry. 277(28). 25344–25355. 9 indexed citations

Pursiheimo, Juha‐Pekka, et al.. (2002). Protein kinase A balances the growth factor‐induced Ras/ERK signaling. FEBS Letters. 521(1-3). 157–164. 33 indexed citations

Määttå, Arto, Panu Jaakkola, & Markku Jalkanen. (1999). Extracellular Matrix-dependent Activation of Syndecan-1 Expression in Keratinocyte Growth Factor-treated Keratinocytes. Journal of Biological Chemistry. 274(14). 9891–9898. 18 indexed citations

Zhou, Fan, et al.. (1997). Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans?. PubMed. 73(2). 166–74. 17 indexed citations

Li, Jin‐Ping, Åsa Hagner-McWhirter, Lena Kjellén, et al.. (1997). Biosynthesis of Heparin/Heparan Sulfate. Journal of Biological Chemistry. 272(44). 28158–28163. 73 indexed citations

Nelimarkka, Lassi, Varpu Kainulainen, Elke Schönherr, et al.. (1997). Expression of Small Extracellular Chondroitin/Dermatan Sulfate Proteoglycans Is Differentially Regulated in Human Endothelial Cells. Journal of Biological Chemistry. 272(19). 12730–12737. 42 indexed citations

10.

Marjamäki, Anne, et al.. (1994). Use of a hollow fiber bioreactor for large-scale production of α2-adrenoceptors in mammalian cells. Journal of Biotechnology. 37(2). 179–184. 13 indexed citations

11.

Jalkanen, Markku, Klaus Elenius, & Alan C. Rapraeger. (1993). Syndecan: Regulator of Cell Morphology and Growth Factor Action at the Cell-matrix Interface.. Trends in Glycoscience and Glycotechnology. 5(22). 107–120. 23 indexed citations

12.

Salmivirta, Markku, Heikki Rauvala, Klaus Elenius, & Markku Jalkanen. (1992). Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Experimental Cell Research. 200(2). 444–451. 85 indexed citations

13.

Jalkanen, Markku, Klaus Elenius, & Markku Salmivirta. (1992). Syndecan — A Cell Surface Proteoglycan that Selectively Binds Extracellular Effector Molecules. Advances in experimental medicine and biology. 313. 79–85. 20 indexed citations

14.

Leppä, Sirpa, Pirkko Härkönen, & Markku Jalkanen. (1991). Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells.. PubMed. 2(1). 1–11. 67 indexed citations

15.

Saunders, Scott, et al.. (1989). Molecular cloning of syndecan, an integral membrane proteoglycan.. The Journal of Cell Biology. 108(4). 1547–1556. 435 indexed citations

16.

Jalkanen, Markku, Alan C. Rapraeger, & Merton Bernfield. (1988). Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins.. The Journal of Cell Biology. 106(3). 953–962. 62 indexed citations

17.

Thesleff, Irma, Markku Jalkanen, Seppo Vainio, & Merton Bernfield. (1988). Cell surface proteoglycan expression correlates with epithelial-mesenchymal interaction during tooth morphogenesis. Developmental Biology. 129(2). 565–572. 153 indexed citations

18.

Jalkanen, Markku. (1987). Biology of cell surface heparan sulfate proteoglycans.. PubMed. 65(1). 41–7. 20 indexed citations

19.

Rapraeger, Alan C., et al.. (1985). The cell surface proteoglycan from mouse mammary epithelial cells bears chondroitin sulfate and heparan sulfate glycosaminoglycans.. Journal of Biological Chemistry. 260(20). 11046–11052. 251 indexed citations

20.

Jalkanen, Markku, Juha Peltonen, & E. Kulonen. (1979). Isoelectric focusing of macrophage culture media and the effect of the fractions on the synthesis of DNA and collagen by fibroblasts.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 87(5). 347–52. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact